Tradr Launches First-to-Market Leveraged ETF on Core Scientific, Inc.

Rhea-AI Summary

Tradr ETFs (Cboe: COZX) launched the Tradr 2X Long CORZ Daily ETF on Nov 5, 2025, seeking 200% daily exposure to Core Scientific (Nasdaq: CORZ). The fund is listed on Cboe and joins Tradr's AI-infrastructure suite.

Tradr reports a lineup of 49 leveraged ETFs representing over $2.2 billion AUM. The product targets sophisticated investors and short-term traders and emphasizes leverage risks, potential divergence from benchmark over periods longer than the reset, and the possibility of total loss if CORZ moves >50% adverse in one day.

Positive

• Seeks 200% daily exposure to CORZ
• Listed on Cboe for exchange trading
• Tradr lineup: 49 leveraged ETFs
• Firm reports $2.2 billion AUM across leveraged ETF lineup

Negative

• Leverage can cause total loss if CORZ drops >50% in one trading day
• Fund performance may diverge materially from CORZ over periods beyond the daily reset
• Intended for short-term use only; increases trading and monitoring demands
• No guarantee an active trading market for ETF shares will develop

Insights

Market Structure & Product Specialist

Tradr listed a 2X single-stock ETF on Core Scientific, expanding its leveraged-product suite but mainly serving short‑term traders.

The fund, listed on Cboe as COZX, seeks 200% daily exposure to CORZ. The issuer notes a lineup of 49 leveraged ETFs and assets of $2.2 billion, framing this as a product for sophisticated, active traders who want leveraged short‑term exposure without using margin or options.

Key dependencies and risks include the fund’s daily reset design, concentrated single‑stock exposure, and the high volatility of the underlying security; these features make the vehicle unsuitable for passive or long‑term holding and increase the chance of outcomes that diverge sharply from the reference security over periods beyond one trading day. Watch intra‑day liquidity in COZX and the ETF’s tracking performance versus CORZ during the first 30–90 days for evidence of market‑maker support and realized tracking error.

COZX targets 200% long daily exposure to this next generation data center leader

NEW YORK, Nov. 5, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched the first single-stock leveraged ETF on Core Scientific, Inc. (Nasdaq: CORZ). Listed on Cboe, the Tradr 2X Long CORZ Daily ETF (Cboe: COZX) seeks to deliver twice (200%) the daily performance of CORZ.

"We are thrilled to have COZX join our industry leading AI-infrastructure suite, which already includes ETFs offering 2X exposure to CoreWeave, Nebius, CleanSpark, Applied Digital, IREN and TeraWulf," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "Core Scientific continues its aggressive transformation from a bitcoin mining play into a data-center powerhouse looking to benefit from America's growing thirst for AI-compute power."

In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia. With today's listing, Tradr's lineup has grown to 49 leveraged ETFs representing over $2.2 billion in assets under management. Tradr's strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.

For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.

About Tradr ETFs
Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

IMPORTANT RISK INFORMATION

Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.

Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.

ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com . The Prospectus should be read carefully before investing.

Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000778

View original content to download multimedia:https://www.prnewswire.com/news-releases/tradr-launches-first-to-market-leveraged-etf-on-core-scientific-inc-302604174.html

SOURCE Tradr ETFs

FAQ

What is the new Tradr ETF COZX announced on Nov 5, 2025?

COZX is the Tradr 2X Long CORZ Daily ETF seeking 200% daily exposure to Core Scientific (CORZ).

How does COZX aim to deliver 2X exposure to CORZ?

COZX seeks to deliver approximately twice the daily performance of CORZ through leveraged strategies reset daily.

Who is the target investor for COZX (Cboe: COZX)?

The fund targets sophisticated investors and professional traders intending short-term, actively managed trades.

What asset scale does Tradr report for its leveraged ETF lineup?

Tradr reports 49 leveraged ETFs representing over $2.2 billion in assets under management.

What are the main risks for investors in COZX?

Key risks include heightened volatility, divergence from benchmark over time, potential total loss if CORZ moves >50% adverse intraday, and possible lack of an active market.

Where can investors find the COZX prospectus and risk details?

Prospectus and important risk information are available at www.tradretfs.com.